Macquarie Group
CALA

Macquarie Group’s Calithera Biosciences, Inc CALA Stock Holding History

Macquarie Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20
Closed -$2K – 2177
2018
Q4 		$2K Sell
20
-31
-61% -$3.06K ﹤0.01% 2209
2018
Q3 		$5K Sell
51
-109
-68% -$10.4K ﹤0.01% 2074
2018
Q2 		$16K Buy
160
+20
+14% +$2.27K ﹤0.01% 2092
2018
Q1 		$18K Sell
140
-1,760
-93% -$274K ﹤0.01% 2093
2017
Q4 		$317K Buy
1,900
+1,670
+726% +$428K ﹤0.01% 1587
2017
Q3 		$72K Buy
+230
New +$72.6K ﹤0.01% 1970

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group's CALA Position: Q1 2019 in Review

Macquarie Group sold out of Calithera Biosciences, Inc (CALA) in Q1 2019, closing a stake of 20 shares — an estimated $2K sold.

Macquarie Group first reported a position in CALA in Q3 2017 and held it in 6 quarters. The position peaked at $317K in Q4 2017. 71 funds tracked by Wall St. Rank hold CALA as of Q1 2019.

  • Macquarie Group reported no remaining Calithera Biosciences, Inc position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 20 Calithera Biosciences, Inc shares in Q1 2019, an estimated $2K.
  • Macquarie Group first reported a position in Calithera Biosciences, Inc in Q3 2017 and held it in 6 quarters.
  • Macquarie Group's Calithera Biosciences, Inc position peaked at $317K in Q4 2017.
  • 71 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.